top of page
Home
About
All News
Contact
More
Use tab to navigate through the menu items.
Rare360.life
Rare Disease News Briefs, Thought Leadership & More
All Posts
Thought Leaders
Community Insights
News Briefs
Living Rare Editorials
The Rare360 Editorial Team
Oct 21, 2024
2 min read
The FDA’s Duloxetine Recall: Implications for Mental Health and Chronic Pain Patients
Thousands of Duloxetine Capsules have been recalled after N-nitroso-duloxetine, a cancer-causing impurity, was detected above safety limit.
bottom of page
